Cizzle Biotechnology Holdings Plc (FRA:E7F0)

Market Cap	5.90M -24.9%
Revenue (ttm)	n/a
Net Income	-1.31M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	161
Average Volume	n/a
Open	0.0130
Previous Close	0.0130
Day's Range	0.0130 - 0.0130
52-Week Range	0.0125 - 0.0250
Beta	n/a
RSI	32.77
Earnings Date	Apr 30, 2026

About FRA:E7F0

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Employees: 4
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: E7F0

Financial Performance

Financial numbers in GBP